بدائل البحث:
significant point » significant amount (توسيع البحث), significant part (توسيع البحث), significant event (توسيع البحث)
point decrease » point increase (توسيع البحث)
new decrease » nn decrease (توسيع البحث), we decrease (توسيع البحث), teer decrease (توسيع البحث)
significant point » significant amount (توسيع البحث), significant part (توسيع البحث), significant event (توسيع البحث)
point decrease » point increase (توسيع البحث)
new decrease » nn decrease (توسيع البحث), we decrease (توسيع البحث), teer decrease (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
B2 decreases glycolytic intermediates in cells.
منشور في 2025"…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …"
-
6
-
7
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
8
-
9
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
10
-
11
-
12
-
13
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
14
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
15
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
16
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
17
-
18
-
19
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
منشور في 2025الموضوعات: -
20
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
منشور في 2025"…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"